Resumen
Objetivo: Evaluar las manifestaciones clínicas bucales identificadas en pacientes positivos a COVID-19, ya sea relacionadas con infección viral o efecto secundario del tratamiento, a través de una encuesta bibliográfica. Métodos: La metodología adoptada consistió en una revisión integradora de la literatura, basada en investigaciones realizadas en reconocidas bases de datos, como Pubmed/Medline y Google Scholar. Se utilizaron estrategias de búsqueda y criterios preestablecidos, utilizando los siguientes descriptores: Coronavirus, Odontología, Manifestaciones bucales y Mucosa bucal. Resultados: La investigación identificó varias manifestaciones orales comunes en pacientes diagnosticados con COVID-19, incluyendo disgeusia, xerostomía y lesiones ulcerativas. Además, se observó una asociación entre una mala higiene bucal y el empeoramiento de la enfermedad, y los estudios indican una alta prevalencia de cambios bucales en los casos graves. El tratamiento de las lesiones bucales implicó el uso de medicamentos específicos y prácticas de higiene adecuadas, destacando el papel fundamental de los profesionales odontológicos en la identificación y manejo de estas manifestaciones, que pueden servir como indicadores de infección por COVID-19. Consideraciones finales: Ante el escenario actual del COVID-19, se necesitan estudios más detallados, que sirvan como herramienta de asistencia a los profesionales de la salud en consultorios, así como a los profesionales de otras instituciones hospitalarias.
Referencias
ABUBAKR N, et al. Oral manifestations in mild-to-moderate cases of COVID-19 viral infection in the adult population. Dent Med Probl., 2021; 58(1): 7-15.
AL-KHANATI NM, et al. Aphthous-like stomatitis of COVID-19 patients: case report and review of evidence. Braz. J. Oral Sci., 2020; 19: e201354.
AMORIM dos SJ, et al. Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations? International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases, 2020; 97: 326-28.
BAEDER FM, et al. Oral lesions in patients infected with SARS-CoV-2: a case series. Research, Society and Development, 2021; 10(4): e45410414349.
BAO Y, et al. 2019-nCoV epidemic: address mental health care to empower society. Lancet, 2020; 395(10224): e37-e38.
BIADSEE A, et al. Olfactory and Oral Manifestations of COVID-19: Sex-Related Symptoms – A Potential Pathway to Early Diagnosis. Otolaryngol Neck Surg., 2020; 163(4): 722-8.
BRAGA DRA, et al. Oral health conditions in people affected by Covid-19. J. Health Biol Sci., 2021; 9(1): 1-8.
BRANDÃO TB, et al. Oral lesions in patients with SARS-CoV-2 infection: could the oral cavity be a target organ? Oral Surg Oral Med Oral Pathol Oral Radiol., 2021; 131(2): e45-e51.
CARRERAS-PRESAS MC, et al. Oral vesiculobullous lesions associated with SARS-CoV2 infection. Oral Dis, 2020; 1-3.
CARRERAS-PRESAS MC, et al. Oral vesiculobullous lesions associated with SARS-CoV-2 infection. Oral Dis., 2020; 27(Suppl 3): 710-12.
CORCHUELO J, et al. Oral manifestations in a patient with a history of asymptomatic COVID-19: Case report. International Journal of Infectious Diseases, 2020; 100: 154-7.
CUEVAS-GONZALEZ MV, et al. COVID-19 and its manifestations in the oral cavity: A systematic review. Medicine, 2021; 100(51): e28327.
DILSIZ A, et al. Oral and ocular manifestations in a patient with coronavirus disease-2019: Clinical presentation and management. Revista da Sociedade Brasileira de Medicina Tropical, 2022; 55.
EDUARDO FP, et al. Oral lesions and saliva alterations of COVID-19 patients in an intensive care unit: A retrospective study. Spec Care Dentist., 2022; 42(5): 494-502.
EDUARDO FP, et al. Salivary SARS-CoV-2 load reduction with mouthwash use: A randomized pilot clinical trial. Heliyon, 2021; 7(6): e07346.
FAVIA G, et al. Covid-19 Symptomatic Patients with Oral Lesions: Clinical and Histopathological Study on 123 Cases of the University Hospital Policlinic of Bari with a Purpose of a New Classification. J Clin Med., 2021; 10(4): 757.
FREITAS JÚNIOR WJL, et al. Oral manifestations in patients affected by COVID-19 and their levels of treatment in environments with dental support: an integrative literature review. Research, Society and Development, 2022; 11(9): e27211931737.
GHERLONE EF, et al. Frequent and Persistent Salivary Gland Ectasia and Oral Disease After COVID-19. J Dent Res., 2021; 100(5): 464-71.
GOMES AVSF, et al. The importance of the Dentist in the COVID-19 ICU. Research, Society and Development, 2021; 10(10): e431101018786.
HALBOUB E, et al. Orofacial manifestations of COVID-19: a brief review of the published literature. Brazilian Oral Research, 2020; 34: e124.
HAN P e IVANOVSKI S. Saliva-Friend and Foe in the COVID-19 Outbreak. Diagnostics (Basel), 2020; 10(5): 290.
HUANG C, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020; 395(10223): 497-506.
ICCARESE G, et al. Letter to the editor. Oral erosions and petechiae during SARS-CoV-2 infection. J Med Virol., 2020: 1-4.
IRANMANESH B, et al. Oral manifestations of COVID 19 disease: A review article. Dermatologic Therapy, 2020.
KAMEL AHM, et al. The impact of oral health status on COVID-19 severity, recovery period and C-reactive protein values. Br Dent J., 2021: 1-7.
LECHIEN JR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol., 2020; 277(8): 2251-61.
MALIH N, et al. Unexpected Presentation of COVID-19 in a 38-Year-Old Male Patient: A Case Report. Case Rep Dermatol., 2020; 12(2): 124-31.
MASCITTI H, et al. Clinical Cutaneous Features of Patients Infected With SARS-CoV-2 Hospitalized for Pneumonia: A Cross-sectional Study. Open Forum Infect Dis., 2020; 7(11): ofaa394.
MATEOS-MORENO MV, et al. Oral antiseptics against coronavirus: in-vitro and clinical evidence. J Hosp Infect., 2021; 113: 30-43.
OMS- Organização Mundial da Saúde. 2020. Disponível em: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline#!. Acessado em: 29 de março de 2024.
PATEL J e WOOLLEY J. Necrotizing periodontal disease: Oral manifestation of COVID-19. Oral Dis., 2021; (27 Suppl 3): 768-9.
PETEL R, et al. Oral manifestations of COVID-19: A living review. Journal of Dental Research, 2020; 100(2): 141-50.
PUELLES VG, et al. Multiorgan and Renal Tropism of SARS-CoV-2. N Engl J Med., 2020; 383(6): 590-92.
PUTRA BE, et al. Viral exanthem with “spins and needles sensation” on extremities of a covid-19 patient: a self-reported case from an indonesian medical frontliner. Int J Infect Dis., 2020; 96: 355-8.
RODRÍGUEZ MD, et al. Oral manifestations associated with COVID 19. Oral Diseases, 2020; (28 Suppl 1): 960-2.
SINADINOS A e SHELSWELL J. Oral ulceration and blistering in patients with COVID-19. Evid Based Dent., 2020; 21(2): 49.
TUON FF, et al. Prospective, randomised, controlled study evaluating early modification of oral microbiota following admission to the intensive care unit and oral hygiene with chlorhexidine. J Glob Antimicrob Resist., 2017; 8: 159-163.
VIAYACHANDRAN D e BALASUBRAMANIAN S. Letter to the editor. Is Gustatory Impairment the First Report of an Oral Manifestation in COVID-19? Oral Dis., 2020.
XIANG Z, et al. Potential implications of SARS-CoV-2 oral infection in the host microbiota. J Oral Microbiol., 2020; 13(1): 1853451.
XIANG, Z., et al. Oral cavity is a potential reservoir for SARS-CoV-2: A review of the current literature. Journal of Dental Research, 2021; 100(3): 261-7.
XU H, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci., 2020; 12(1): 8.
